Nature Reviews Cancer

Nature Reviews Cancer abbreviation - Nat Rev Cancer

Journal Name Nature Reviews Cancer
Abbreviation Nat Rev Cancer
Journal Start Year 2001
Print ISSN 1474-175X
Online ISSN 1474-1768
Subject Biochemistry
Sub Subject Medicine
Country United Kingdom (GB)
Publisher Nature Publishing Group
Journal Details Journal Website
Rss Feed
Subscribe Subscribe Journals

About Journal :

Nature Reviews Cancer aims to be the premier source of reviews and commentaries for the scientific communities we serve. We strive to publish articles that are authoritative, accessible and enhanced with clearly understandable figures, tables and other display items. We want to provide unparalleled service to authors, referees and readers, and we work hard to maximize the usefulness and impact of each article. The journal publishes Research Highlights, Comments, Reviews and Perspectives relevant to cancer researchers, with our broad scope ensuring that the articles we publish reach the widest possible audience. 

 

Aims & Scope

The ultimate aim of cancer research is to eliminate this common and devastating disease from the human population. To develop more effective prevention methods we need to understand what triggers tumorigenesis. To diagnose precancerous lesions and early-stage cancers quickly and accurately we need to detect the earliest molecular changes leading to each type of cancer. To determine a patient's prognosis we need to appreciate which molecular changes affect tumour growth rate and metastasis. And to tailor therapies to individual tumours we need to understand the fundamental differences, not only between a cancer cell and a 'normal' cell, but also between one cancer cell and another. All of these goals depend on a combination of basic and applied research. Nature Reviews Cancer aims to be a gateway from which cancer researchers — from those investigating the molecular basis of cancer to those involved in translational research — access the information that they need to further the ability to diagnose, treat and ultimately prevent cancer.

 

Aims & Scope

The ultimate aim of cancer research is to eliminate this common and devastating disease from the human population. To develop more effective prevention methods we need to understand what triggers tumorigenesis. To diagnose precancerous lesions and early-stage cancers quickly and accurately we need to detect the earliest molecular changes leading to each type of cancer. To determine a patient's prognosis we need to appreciate which molecular changes affect tumour growth rate and metastasis. And to tailor therapies to individual tumours we need to understand the fundamental differences, not only between a cancer cell and a 'normal' cell, but also between one cancer cell and another. All of these goals depend on a combination of basic and applied research. Nature Reviews Cancer aims to be a gateway from which cancer researchers — from those investigating the molecular basis of cancer to those involved in translational research — access the information that they need to further the ability to diagnose, treat and ultimately prevent cancer.

Subjects Covered:

  • Genomic instability: chromosomal and microsatellite instabilities, defects in DNA repair pathways.
  • Growth promoting signals: dysregulation of growth factor signalling pathways and cell cycle progression, proto-oncogenes and their activation.
  • Growth inhibitory signals: dysregulation of quiescence and differentiation, tumour suppressors and their inactivation.
  • Cancer stem cells.
  • Cell death: evading programmed cell death, including avoidance of immune surveillance systems.
  • Metabolism: pathways of nutrient acquisition and metabolism in tumour cells and cells of the tumour microenvironment, effects of systemic metabolism on cancer initiation and progression.
  • Tumour microenvironment:  immune and stromal cells, tumour vasculature, extracellular matrix components, cell–cell communication.
  • Tumour evolution and heterogeneity.
  • Metastasis:  tumour cell dissemination, dormancy and growth in new microenvironments.
  • Carcinogenesis and cancer prevention: epidemiology, genetic and environmental triggers, gene–environment interactions, strategies for reducing risk.
  • Cancer diagnosis and prognosis: molecular markers, diagnostic imaging, detecting minimal residual disease.
  • New approaches to cancer therapy: rational drug design, gene therapy, immunotherapy, combination therapies, combating drug resistance, targeting therapies to the individual.
  • Experimental systems and techniques: cell culture systems, animal and patient-derived models, genomic, epigenomic, proteomic and metabolomic approaches to studying cancer.
  • Cancer-associated disease: cancer pain, cachexia, symptoms associated with treatment, psychosocial aspects of cancer.
  • Ethical, legal and social issues surrounding cancer research: trial design, genetic screening, research policy, advocacy.
  • Conventional approaches to cancer diagnosis and treatment: how do they perform, what are their drawbacks and how might they be improved in the future?





Nature Reviews Cancer FAQs

Journal Short description?

Nature Reviews Cancer is a Biochemistry and Medicine Journal and published by Nature Publishing Group. See also a list of biochemistry and medicine journals.

What is the abbreviation of Nature Reviews Cancer?

An abbreviation is a shortened form of a word or phrase, by any method. It may consist of a group of letters or words taken from the full version of the word or phrase.

The ISO4 Abbreviation of Nature Reviews Cancer is Nat Rev Cancer.

Nature Reviews Cancer abbreviation

What is the ISSN Details?

An International Standard Serial Number is an eight-digit serial number used to uniquely identify a serial publication, such as a magazine. The ISSN is especially helpful in distinguishing between serials with the same title

"Nature Reviews Cancer" Journal Print ISSN : 1474-175X, and Online ISSN (eISSN) : 1474-1768

Nature Reviews Cancer Print ISSN : 1474-175X
Nature Reviews Cancer eISSN : 1474-1768

Is Nature Reviews Cancer UGC Approved Journal (UGC Indexed)?

The University Grants Commission of India (UGC India) is the primary regulatory body created by the Indian Government in accordance with the UGC Act of 1956 under the Ministry of Human Resource Development. It has been made responsible for the coordination of Indian Universities, determination of the standards for Indian universities and maintenance of standards of higher education in India.

Yes Nature Reviews Cancer is Indexed By UGC Care. you also can visit in UGC care list, may be they have updated their list. get a list of ugc approved journals.

Is Nature Reviews Cancer Pubmed Indexed Journal?

PubMed is a free search engine accessing primarily the MEDLINE database of references and abstracts on life sciences and biomedical topics. The United States National Library of Medicine at the National Institutes of Health maintain the database as part of the Entrez system of information retrieval.

Yes the Nature Reviews Cancer is PUBMED Indexed Journal.

Nature Reviews Cancer PUBMED Indexed Journal : Nature Reviews Cancer PUBMED Indexed Journal

Is Nature Reviews Cancer Peer Reviewed?

Peer review means that a board of scholarly reviewers in the domain of the journal, review materials they publish for quality of research and adherence to editorial standards of the journal, before articles are accepted for publication.

It’s the ultimate litmus test for scientists and researchers to verify their findings.

When an article on an experiment and its hypothesis is submitted to a scholarly journal for publishing then it is meticulously tested.

If a journal makes an article goes through the process of β€˜peer-review’ before being published then it is a peer-review journal.

Yes Nature Reviews Cancer is Peer-Reviewed Journal and Published by Nature Publishing Group.

Nature Reviews Cancer Indexing details?

The Nature Reviews Cancer Journal is Indexed with Pubmed, Scopus, UGC (University Grants Commission).

Nature Reviews Canceris PUBMED Indexed Journal : Nature Reviews Cancer PUBMED Indexed Journal
Nature Reviews Cancer is Web of Science Indexed Journal : Nature Reviews Cancer Web of Science Indexed Journal
Nature Reviews Cancer is UGC Approved Journal : Nature Reviews Cancer UGC Approved Journal

What is the Impact factor of Nature Reviews Cancer?

The Impact factor is also known by the name of journal impact factor of an academic journal. It is based on the scientometric index that shows the annual average number of citations. Moreover, impact factor is having all the information which is published in the last two years in the given journal received.

What is a good impact factor?

Before moving forward, it is essential to know about the necessary information about the impact factor. The definition of impact factor is the number of citations, the articles published in that journal during the last two preceding years, in the given year and divide this by the total number of citable items, which published in that journal in the previous two years.

On the other hand, along with the impact factor, it is important to know about the functional impact factor. Well, we all know that watch the numbers and higher will win. But the impact factor works beyond this and shows that numbers are not absolute. In other words, we can say that the higher the impact factor, the higher the rank of a journal.

The Nature Reviews Cancer Impact factor is 60.716 (2022) Impact factor .

Nature Reviews Cancer Impact Factor : 60.716 (2022)
Note : This information is taken from the Journal Citation Reportsβ„’ (Clarivate).

Visit for all Journals Impact factor List

See also for Biochemistry and Medicine Journals

List of Biochemistry journals
Indian Biochemistry journals list
United states - US Biochemistry journals list
United kingdom Biochemistry journals list
List of Medicine journals
Top 20 Medicine journals




Medicine Related Journals